Cytodyn Inc CYDY Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.20 up $0.00, 0.55% at close Oct 14
Last close · Previous close $0.20
- Market cap
- At the Oct 14 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- Last 12 months
Price chart
$0.20up $0.00, 0.56%Wed, Oct 14 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.20Oct 13
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Valuation
Financials
Dividends
About Cytodyn Inc
CytoDyn Inc. is a development-stage biotechnology company focused on discovering and developing a class of therapeutic monoclonal antibodies to treats Human Immunodeficiency Virus (HIV) infection. In addition, the Company formed a wholly owned subsidiary, CytoDyn Veterinary Medicine LLC (CVM), which will explore the possible application of its existing monoclonal antibody technology to the treatment of Feline Immunodeficiency Virus, a retroviral infection in cats (FIV). CytoDyn and Cytolin are the registered trademarks of the Company. In October 2012, the Company acquired PRO 140, an experimental humanized monoclonal antibody (mAb) targeting the CCR5 receptor for the treatment and prevention of HIV, from Progenics Pharmaceuticals, Inc. PRO 140 is a humanized monoclonal antibody designed to block HIV from entering a cell. Cytolin is the Company's lead product. It targets a normal cell molecule called CD11a.
- Sector
- Industry
- Headquarters
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
CYDY news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
CYDY stock FAQ
What is CYDY stock’s price today?
Cytodyn (CYDY) traded at $0.20 at the close on , unchanged from the previous close of $0.20.
What exchange does CYDY trade on?
Cytodyn trades on the PINK under the ticker symbol CYDY. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.